Sodium Glucose Cotransporter 2 Inhibitors, Amputation Risk, and Fracture Risk

被引：11
|
作者：
Arnott, Clare [1 ,2 ,3 ]
Fletcher, Robert A. [1 ]
Neal, Bruce [1 ,4 ]
机构：
[1] Univ New South Wales, George Inst Global Hlth, Level 5,1 King St, Sydney, NSW 2042, Australia
[2] Royal Prince Alfred Hosp, Dept Cardiol, Sydney, NSW, Australia
[3] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia
[4] Imperial Coll London, Dept Epidemiol & Biostat, London, England
来源：
HEART FAILURE CLINICS | 2022年 / 18卷 / 04期
关键词：
SGLT2; inhibitors; Meta-analysis; Amputation; Fracture; TYPE-2; CANAGLIFLOZIN;
D O I：
10.1016/j.hfc.2022.03.008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：645 / 654
页数：10
相关论文
共 50 条
  • [31] Sodium-glucose cotransporter type 2 inhibitors and cardiac arrhythmias
    Manolis, Antonis A.
    Manolis, Theodora A.
    Melita, Helen
    Manolis, Antonis S.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2023, 33 (07) : 418 - 428
  • [32] Sodium-glucose cotransporter 2 inhibitors for the management of type 2 diabetes
    Siamashvili, Maka
    Davis, Stephen N.
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (16) : 2181 - 2198
  • [33] Glucose Lowering Efficacy and Pleiotropic Effects of Sodium-Glucose Cotransporter 2 Inhibitors
    Kuchay, Mohammad Shafi
    Farooqui, Khalid Jamal
    Mishra, Sunil Kumar
    Mithal, Ambrish
    DIABETES: FROM RESEARCH TO CLINICAL PRACTICE, VOL 4, 2021, 1307 : 213 - 230
  • [34] Sodium-glucose cotransporter-2 inhibitors and risk for genitourinary infections in older adults with type 2 diabetes
    Varshney, Navya
    Billups, Sarah J.
    Saseen, Joseph J.
    Fixen, Cy W.
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2021, 12
  • [35] Risk of limb amputation and bone fractures with sodium glucose cotransporter-2 inhibitors: a network meta-analysis and meta-regression
    Sridharan, Kannan
    Sivaramakrishnan, Gowri
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [36] Heart and Sodium-Glucose Cotransporter 2 Inhibitors: A Sodium Dilemma
    Oyesomi, Elizabeth T.
    Tabrizchi, Reza
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022, 79 (05) : 641 - 643
  • [37] Sodium-glucose cotransporter 2 inhibitors and fracture risk in patients with type 2 diabetes mellitus: A systematic literature review and Bayesian network meta-analysis of randomized controlled trials
    Azharuddin, Md
    Adil, Mohammad
    Ghosh, Pinaki
    Sharmaa, Manju
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 146 : 180 - 190
  • [38] Effects of sodium-glucose cotransporter 2 inhibitors on renal risk factors in patients with abnormal glucose metabolism: a meta-analysis of randomized controlled trials
    Li, Mengnan
    Zhang, Jian
    Yang, Guimei
    Zhang, Jiaxin
    Han, Minmin
    Zhang, Yi
    Liu, Yunfeng
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 79 (06) : 859 - 871
  • [39] Decreased risk of renal cell carcinoma in patients with type 2 diabetes treated with sodium glucose cotransporter-2 inhibitors
    Chiu, Chun-Huei
    Wang, Wei-Yao
    Chen, Hung-Yi
    Liao, Pei-Lun
    Jong, Gwo-Ping
    Yang, Tsung-Yuan
    CANCER SCIENCE, 2024, 115 (06) : 2059 - 2066
  • [40] Sodium-Glucose Cotransporter 2 Inhibitors: A Case Study in Translational Research
    Beitelshees, Amber L.
    Leslie, Bruce R.
    Taylor, Simeon I.
    DIABETES, 2019, 68 (06) : 1109 - 1120
12345